All Cosmos Bio-Tech Holding Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 777.97 million compared to TWD 665.65 million a year ago. Net income was TWD 40.33 million compared to TWD 68.51 million a year ago.

Basic earnings per share from continuing operations was TWD 0.63 compared to TWD 1.07 a year ago. Diluted earnings per share from continuing operations was TWD 0.63 compared to TWD 1.07 a year ago.